{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T22:54:32Z","timestamp":1789512872218,"version":"build-2803163510"},"reference-count":35,"publisher":"The Endocrine Society","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,8,1]]},"DOI":"10.1210\/jc.2006-0190","type":"journal-article","created":{"date-parts":[[2006,5,10]],"date-time":"2006-05-10T03:35:54Z","timestamp":1147232154000},"page":"2882-2887","source":"Crossref","is-referenced-by-count":121,"title":["Effects of Teriparatide, Alendronate, or Both on Bone Turnover in Osteoporotic Men"],"prefix":"10.1210","volume":"91","author":[{"given":"Joel S.","family":"Finkelstein","sequence":"first","affiliation":[{"name":"Endocrine Unit, Department of Medicine (J.S.F., B.Z.L., S.-A.M.B., J.J.W., K.G., A.V.d.l.P., R.M.N.) Boston, Massachusetts 02114"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin Z.","family":"Leder","sequence":"additional","affiliation":[{"name":"Endocrine Unit, Department of Medicine (J.S.F., B.Z.L., S.-A.M.B., J.J.W., K.G., A.V.d.l.P., R.M.N.) Boston, Massachusetts 02114"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherri-Ann M.","family":"Burnett","sequence":"additional","affiliation":[{"name":"Endocrine Unit, Department of Medicine (J.S.F., B.Z.L., S.-A.M.B., J.J.W., K.G., A.V.d.l.P., R.M.N.) Boston, Massachusetts 02114"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason J.","family":"Wyland","sequence":"additional","affiliation":[{"name":"Endocrine Unit, Department of Medicine (J.S.F., B.Z.L., S.-A.M.B., J.J.W., K.G., A.V.d.l.P., R.M.N.) Boston, Massachusetts 02114"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang","family":"Lee","sequence":"additional","affiliation":[{"name":"Biostatistics Center (H.L.), Massachusetts General Hospital, Boston, Massachusetts 02114"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda Victoria","family":"de la Paz","sequence":"additional","affiliation":[{"name":"Endocrine Unit, Department of Medicine (J.S.F., B.Z.L., S.-A.M.B., J.J.W., K.G., A.V.d.l.P., R.M.N.) Boston, Massachusetts 02114"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Gibson","sequence":"additional","affiliation":[{"name":"Endocrine Unit, Department of Medicine (J.S.F., B.Z.L., S.-A.M.B., J.J.W., K.G., A.V.d.l.P., R.M.N.) Boston, Massachusetts 02114"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert M.","family":"Neer","sequence":"additional","affiliation":[{"name":"Endocrine Unit, Department of Medicine (J.S.F., B.Z.L., S.-A.M.B., J.J.W., K.G., A.V.d.l.P., R.M.N.) Boston, Massachusetts 02114"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"key\n\t\t\t\t2019041114154732500_R1","first-page":"1547","article-title":"Osteoporosis","author":"Finkelstein","year":"2004","journal-title":"In: Goldman, L, Ausiello, D, eds. Cecil textbook of medicine. 22nd ed. Philadelphia: Saunders;"},{"key":"key\n\t\t\t\t2019041114154732500_R2","first-page":"1","article-title":"Epidemiology of fractures","author":"Melton","year":"1999","journal-title":"In: Orwoll, ES, ed. Osteoporosis in men. The effects of gender on skeletal health. San Diego: Academic Press;"},{"key":"key\n\t\t\t\t2019041114154732500_R3","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1073\/pnas.96.1.133","article-title":"Alendronate mechanism of action: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitro","volume":"96","author":"Fisher","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"key\n\t\t\t\t2019041114154732500_R4","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1056\/NEJM199511303332201","article-title":"Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis","volume":"333","author":"Liberman","year":"1995","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041114154732500_R5","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/S0140-6736(96)07088-2","article-title":"Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures","volume":"348","author":"Black","year":"1996","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2019041114154732500_R6","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1056\/NEJM199809103391104","article-title":"Endogenous hormones and the risk of hip and vertebral fractures among older women. Study of Osteoporotic Fractures Research Group","volume":"339","author":"Cummings","year":"1998","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041114154732500_R7","doi-asserted-by":"crossref","first-page":"5252","DOI":"10.1210\/jcem.86.11.7988","article-title":"Alendronate treatment of established primary osteoporosis in men: results of a 2-year prospective study","volume":"86","author":"Ringe","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114154732500_R8","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1056\/NEJM200008313430902","article-title":"Alendronate for the treatment of osteoporosis in men","volume":"343","author":"Orwoll","year":"2000","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041114154732500_R9","first-page":"3069","article-title":"Parathyroid hormone as a therapy for idiopathic osteoporosis in men: effects on bone mineral density and bone markers","volume":"85","author":"Kurland","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114154732500_R10","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1359\/jbmr.2003.18.1.9","article-title":"The effect of teriparatide [human parathyroid hormone (1\u201334)] therapy on bone density in men with osteoporosis","volume":"18","author":"Orwoll","year":"2003","journal-title":"J Bone Miner Res"},{"key":"key\n\t\t\t\t2019041114154732500_R11","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1056\/NEJM199412153312404","article-title":"Parathyroid hormone for the prevention of bone loss induced by estrogen deficiency","volume":"331","author":"Finkelstein","year":"1994","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041114154732500_R12","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1001\/jama.280.12.1067","article-title":"Prevention of estrogen deficiency-related bone loss with human parathyroid hormone-(1\u201334): a randomized, controlled trial","volume":"280","author":"Finkelstein","year":"1998","journal-title":"JAMA"},{"key":"key\n\t\t\t\t2019041114154732500_R13","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1056\/NEJM200105103441904","article-title":"Effect of parathyroid hormone (1\u201334) on fractures and bone mineral density in postmenopausal women with osteoporosis","volume":"344","author":"Neer","year":"2001","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041114154732500_R14","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1056\/NEJMoa035725","article-title":"The effects of parathyroid hormone, alendronate, or both in men with osteoporosis","volume":"349","author":"Finkelstein","year":"2003","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041114154732500_R15","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1056\/NEJMoa031975","article-title":"The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis","volume":"349","author":"Black","year":"2003","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041114154732500_R16","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/00004424-198505000-00014","article-title":"Quantitative computed tomography for spinal density measurement. Factors affecting precision","volume":"20","author":"Rosenthal","year":"1985","journal-title":"Invest Radiol"},{"key":"key\n\t\t\t\t2019041114154732500_R17","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0002-9343(97)00137-X","article-title":"Biochemical markers in the assessment of bone disease","volume":"103","author":"Bikle","year":"1997","journal-title":"Am J Med"},{"key":"key\n\t\t\t\t2019041114154732500_R18","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1359\/jbmr.1998.13.6.1051","article-title":"Alendronate does not block the anabolic effect of PTH in postmenopausal osteoporotic women","volume":"13","author":"Cosman","year":"1998","journal-title":"J Bone Miner Res"},{"key":"key\n\t\t\t\t2019041114154732500_R19","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s007740170048","article-title":"Treatment with parathyroid peptides and estrogen replacement for severe postmenopausal vertebral osteoporosis: prediction of long-term responses in spine and femur","volume":"19","author":"Reeve","year":"2001","journal-title":"J Bone Miner Metab"},{"key":"key\n\t\t\t\t2019041114154732500_R20","first-page":"S137","article-title":"Parathyroid hormone 1\u201334 (hPTH 1\u201334) and estrogen produce dramatic bone density increases in postmenopausal osteoporosis: results from a placebo-controlled randomized trial","volume":"14","author":"Roe","year":"1999","journal-title":"J Bone Miner Res"},{"key":"key\n\t\t\t\t2019041114154732500_R21","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/S0140-6736(97)02342-8","article-title":"Randomised controlled study of effect of parathyroid hormone on vertebral-bone mass and fracture incidence among postmenopausal women on oestrogen with osteoporosis","volume":"350","author":"Lindsay","year":"1997","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2019041114154732500_R22","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1359\/jbmr.040117","article-title":"Differential effects of teriparatide on BMD after treatment with raloxifene or alendronate","volume":"19","author":"Ettinger","year":"2004","journal-title":"J Bone Miner Res"},{"key":"key\n\t\t\t\t2019041114154732500_R23","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1359\/JBMR.050714","article-title":"Combination teriparatide and raloxifene therapy for postmenopausal osteoporosis: results from a 6-month double-blind placebo-controlled trial","volume":"20","author":"Deal","year":"2005","journal-title":"J Bone Miner Res"},{"key":"key\n\t\t\t\t2019041114154732500_R24","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/0006-291X(89)92795-2","article-title":"Activation of the bone derived latent TGF-\u03b2 complex by isolated osteoclasts","volume":"158","author":"Oreffo","year":"1989","journal-title":"Biochem Biophys Res Commun"},{"key":"key\n\t\t\t\t2019041114154732500_R25","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.molmed.2004.12.004","article-title":"Osteoclast-derived activity in the coupling of bone formation to resorption","volume":"11","author":"Martin","year":"2005","journal-title":"Trends Mol Med"},{"key":"key\n\t\t\t\t2019041114154732500_R26","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1172\/JCI6610","article-title":"Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone","volume":"104","author":"Jilka","year":"1999","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t2019041114154732500_R27","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1172\/JCI113885","article-title":"Insulin-like growth factor I mediates selective anabolic effects of parathyroid hormone in bone cultures","volume":"83","author":"Canalis","year":"1989","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t2019041114154732500_R28","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1210\/endo-124-3-1247","article-title":"Parathyroid hormone enhances the transcript and polypeptide levels of insulin-like growth factor I in osteoblast enriched cultures from fetal rat bone","volume":"124","author":"McCarthy","year":"1989","journal-title":"Endocrinology"},{"key":"key\n\t\t\t\t2019041114154732500_R29","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/8756-3282(90)90136-M","article-title":"Parathyroid hormone blocks the stimulatory effect of insulin-like growth factor-I on collagen synthesis in cultured 21-day fetal rat calvariae","volume":"11","author":"Kream","year":"1990","journal-title":"Bone"},{"key":"key\n\t\t\t\t2019041114154732500_R30","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1385\/BTER:104:2:131","article-title":"Bone-specific alkaline phosphatase activity is inhibited by bisphosphonates: role of divalent cations","volume":"104","author":"Vaisman","year":"2005","journal-title":"Biol Trace Elem Res"},{"key":"key\n\t\t\t\t2019041114154732500_R31","doi-asserted-by":"crossref","first-page":"4528","DOI":"10.1210\/jc.2002-020334","article-title":"A randomized double-blind trial to compare the efficacy of teriparatide [recombinant human parathyroid hormone (1\u201334)] with alendronate in postmenopausal women with osteoporosis","volume":"87","author":"Body","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114154732500_R32","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1359\/JBMR.050105","article-title":"Early changes in biochemical markers of bone formation predict BMD response to teriparatide in postmenopausal women with osteoporosis","volume":"20","author":"Chen","year":"2005","journal-title":"J Bone Miner Res"},{"key":"key\n\t\t\t\t2019041114154732500_R33","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1007\/s001980070111","article-title":"Short-term increases in bone turnover markers predict parathyroid hormone-induced spinal bone mineral density gains in postmenopausal women with glucocorticoid-induced osteoporosis","volume":"11","author":"Lane","year":"2000","journal-title":"Osteoporos Int"},{"key":"key\n\t\t\t\t2019041114154732500_R34","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1001\/archinte.165.15.1762","article-title":"Opposite bone remodeling effects of teriparatide and alendronate in increasing bone mass","volume":"165","author":"McClung","year":"2005","journal-title":"Arch Intern Med"},{"key":"key\n\t\t\t\t2019041114154732500_R35","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/jbmr.5650010411","article-title":"Restoration of spinal bone in osteoporotic men by treatment with human parathyroid hormone (1\u201334) and 1,25-dihydroxyvitamin D","volume":"1","author":"Slovik","year":"1986","journal-title":"J Bone Miner Res"}],"container-title":["The Journal of Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/91\/8\/2882\/10442100\/jcem2882.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,18]],"date-time":"2019-04-18T19:09:37Z","timestamp":1555614577000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/91\/8\/2882\/2656344"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8,1]]},"references-count":35,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2006,8,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2006-0190","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,8,1]]}}}